Strong vaccine responses during chemotherapy are associated with prolonged cancer survival
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
A strong vaccine-induced T cell response during standard-of-care chemotherapy correlates with survival in patients with advanced cervical cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Wolchok, J. D., Chiarion-Sileni, V., Gonzalez, R., Rutkowski, P., Grob, J.-J., Cowey, C. L., Lao, C. D., Wagstaff, J., Schadendorf, D., Ferrucci, P. F., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709684 · Cited by 5,357
Improved Survival with Bevacizumab in Advanced Cervical Cancer
Tewari, K. S., Sill, M. W., Long, H. J., Penson, R. T., Huang, H., Ramondetta, L. M., Landrum, L. M., Oaknin, A., Reid, T. J., Leitao, M. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1309748 · Cited by 1,504
Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels.
(1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-5-678_2 · Cited by 1,471
PD-1 Blockade with pembrolizumab in advanced Merkel-cell carcinoma
Nghiem, P. T., Bhatia, S., Lipson, E. J., Kudchadkar, R. R., Miller, N. J., Annamalai, L., Berry, S., Chartash, E. K., Daud, A., Fling, S. P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603702 · Cited by 1,258
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
Kenter, G. G., Welters, M. J. P., Valentijn, A. R. P. M., Lowik, M. J. G., Berends-van der Meer, D. M. A., Vloon, A. P. G., Essahsah, F., Fathers, L. M., Offringa, R., Drijfhout, J. W., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810097 · Cited by 1,102
Self-citationCombination cancer immunotherapies tailored to the tumour microenvironment
Smyth, M. J., Ngiow, S. F., Ribas, A., & Teng, M. W. L. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.209 · Cited by 944
Lyford-Pike, S., Peng, S., Young, G. D., Taube, J. M., Westra, W. H., Akpeng, B., Bruno, T. C., Richmon, J. D., Wang, H., Bishop, J. A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2384 · Cited by 777
Trimble, C. L., Morrow, M. P., Kraynyak, K. A., Shen, X., Dallas, M., Yan, J., Edwards, L., Parker, R. L., Denny, L., Giffear, M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00239-1 · Cited by 727
Vaccines for established cancer: overcoming the challenges posed by immune evasion
van der Burg, S. H., Arens, R., Ossendorp, F., van Hall, T., & Melief, C. J. M. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.16 · Cited by 709 · cited 1×
“In general, the immune system of patients with late-stage cancer is compromised to such an extent that vaccine monotherapy generally fails (28).”
BackgroundSelf-citation
Cited by
Saxena, M., van der Burg, S. H., Melief, C. J. M., & Bhardwaj, N. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00346-0 · Cited by 1,581
Self-citationCombination strategies to maximize the benefits of cancer immunotherapy
Zhu, S., Zhang, T., Zheng, L., Liu, H., Song, W., Liu, D., Li, Z., & Pan, C.-X. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01164-5 · Cited by 654
Therapeutic cancer vaccines: Advancements, challenges, and prospects
Fan, T., Zhang, M., Yang, J., Zhu, Z., Cao, W., & Dong, C. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01674-3 · Cited by 597
“173 212 Developing immunotherapy-based combination therapies (e.g., CTLA4, PD-1/PD-L1) has emerged as a prominent trend in the fi eld of cancer vaccine application (discussed in the combined therapy section above).”
BackgroundRational combinations of targeted cancer therapies: background, advances and challenges
Jin, H., Wang, L., & Bernards, R. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00615-z · Cited by 503
Cervical Cancer Immunotherapy: Facts and Hopes
Ferrall, L., Lin, K. Y., Roden, R. B. S., Hung, C.-F., & Wu, T.-C. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2833 · Cited by 395
“Nearly 43% of patients demonstrated tumor regression, and patients mounted a HPV16-specific T-cell response (192).”
Background
Metadata
- Authors
- Melief, C. J. M., Welters, M. J. P., Vergote, I., Kroep, J. R., Kenter, G. G., Ottevanger, P. B., Tjalma, W. A. A., Denys, H., van Poelgeest, M. I. E., Nijman, H. W., Reyners, A. K. L., Velu, T., Goffin, F., Lalisang, R. I., Loof, N. M., Boekestijn, S., Krebber, W. J., Hooftman, L., Visscher, S., Blumenstein, B. A., Stead, R. B., Gerritsen, W., & van der Burg, S. H.
- Affiliations
- Leiden University Medical Center (NL)
- Universitair Ziekenhuis Leuven (BE)
- Centrum voor Gynaecologische Oncologie Amsterdam (NL)
- Radboud University Medical Center (NL)
- Antwerp University Hospital (BE)
- Ghent University Hospital (BE)
- Department of Gynecology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, Netherlands.
- University Medical Center Groningen (NL)
- Centre Hospitalier Interrégional Edith Cavell (BE)
- Chirec Cancer Institute, Medical Centre Edith Cavell, Rue Edith Cavell 32, 1180 Brussels, Belgium.
- Maastricht University Medical Centre (NL)
- ISA Pharmaceuticals (Netherlands) (NL)
- Trial Architecture Consulting, 4703 Morgan Dr., Chevy Chase, MD 20815, USA.
- BioPharma Consulting Services, 691 96th Avenue Southeast, Bellevue, WA 98004, USA.
- Oncode Institute, Jaarbeursplein 6, 3521 AL Utrecht, Netherlands.
- Corresponding author
- Melief, Cornelis J. M.
- Welters, Marij J. P.
- Gerritsen, Winald
- ORCID
- Melief, Cornelis J. M.
- Welters, Marij J. P.
- Vergote, Ignace
- Kroep, Judith R.
- Kenter, Gemma G.
- Ottevanger, Petronella B.
- Tjalma, Wiebren A. A.
- Denys, Hannelore
- Nijman, Hans W.
- Reyners, Anna K. L.
- Velu, Thierry
- Lalisang, Roy I.
- Loof, Nikki M.
- Boekestijn, Sanne
- Visscher, Sonja
- Blumenstein, Brent A.
- Stead, Richard B.
- Gerritsen, Winald
- van der Burg, Sjoerd H.
- Venue
- Science Translational Medicine
- Published
- 2020-03-18
- Volume
- 12
- Issue
- 535
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W3012160408
- Cited by
- 134
- References
- 43
- Citations by year
- 2026: 14 · 2025: 17 · 2024: 15 · 2023: 22 · 2022: 25 · 2021: 26 · 2020: 14
- FWCI
- 7.61
- Type
- journal article
- Language
- en
- Open access
- green
- research.rug.nl
- Licence
- other-oa
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, other-oa)
- ORBi (University of Liège) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Lirias (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion)
- Funders
- dutch cancer society (2009-4400)
- ISA Pharmaceuticals (N/A)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- therapeutic cancer vaccines, HPV16, cervical cancer, paclitaxel-carboplatin chemotherapy, chemoimmunotherapy, myeloid-derived suppressor cells, antitumor immunity, vaccine-induced T cell responses, cancer survival
- MeSH terms
- Uterine Cervical Neoplasms, Female, Humans, Cancer Vaccines, Papillomavirus Infections, Papillomavirus E7 Proteins, Human papillomavirus 16, Papillomavirus Vaccines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Strong vaccine responses during chemotherapy are associated with prolonged cancer survival. https://app.cochat.ai/papers/10.1126/scitranslmed.aaz8235
- The paper
- Melief, C. J. M., Welters, M. J. P., Vergote, I., Kroep, J. R., Kenter, G. G., Ottevanger, P. B., Tjalma, W. A. A., Denys, H., van Poelgeest, M. I. E., Nijman, H. W., Reyners, A. K. L., Velu, T., Goffin, F., Lalisang, R. I., Loof, N. M., Boekestijn, S., Krebber, W. J., Hooftman, L., Visscher, S., . . . van der Burg, S. H. (2020). Strong vaccine responses during chemotherapy are associated with prolonged cancer survival. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aaz8235
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.